Everything below concerns actin binding. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-08-07. Where a claim depends on a specific study, the study is described rather than over-claimed.
Literature and online discussion often conflate TB-500 with full-length thymosin beta-4, even though the two differ in size and are not interchangeable in analytical terms. The fragment is produced by solid-phase peptide synthesis, and the product is a defined seven-residue chain rather than a biological extract. Because the term is a trade-style label, two vendors may supply materials of the same nominal sequence but different counter-ion content, purity, or water content. Comparisons across studies are therefore difficult unless the exact sequence and purity are reported.
TB-500 is a research peptide whose sequence matches residues 17 to 23 of thymosin beta-4, a 43-residue protein present in most mammalian cells. The chain is seven amino acids long, written as LKKTETQ, and is normally supplied with an acetyl group on the N-terminus. Suppliers list it as a lyophilised powder under the code name TB-500, and the same sequence appears elsewhere in catalogues as the thymosin beta-4 actin-binding fragment. The label is commercial rather than systematic, so no single authority fixes exactly what TB-500 denotes.
Proposed activity centers on actin sequestration and on the movement of cells during repair processes. In cell culture and animal models, the fragment has been associated with migration, tube formation, and tissue remodeling. These observations are frequently described as preliminary, because most published work uses rodent or in vitro systems rather than controlled human trials. Whether the short fragment reproduces the effects of the full protein remains an open question, and the relationship between dose, route, and measured outcome is not well characterized.
The compound circulates in the literature as a research reagent rather than an approved therapeutic. Regulatory agencies in several countries have not authorized it for medical use, and sporting bodies list related thymosin beta-4 peptides among prohibited substances. Suppliers typically market it with a purity figure and a certificate of analysis, while peer-reviewed clinical reports remain sparse. Discussions therefore often separate laboratory findings from anecdotal reports, and reviewers tend to note the small size and methodological limits of the available studies.
TB-500 refers to a synthetic peptide fragment derived from the actin-binding region of thymosin beta-4, a protein present in most mammalian cells. The full protein contains forty-three amino acids, while the commonly sold fragment is a much shorter acetylated sequence, often cited as LKKTETQ. The fragment retains part of the actin-binding motif but lacks the remainder of the parent protein. Material sold under this name is usually lyophilized powder intended for laboratory research, and it is not a finished pharmaceutical product.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Supplied as a lyophilised cake in sealed vials |
| Solubility class | Freely soluble in water | Polar and charged side chains dominate the sequence |
| Typical storage temperature | -20 °C or below | Dry and dark; a desiccant is often recommended |
| Identity confirmation | Mass spectrometry | Observed mass compared with the theoretical value |
| Common synonyms | Thymosin beta-4 fragment | Also written as T beta 4 fragment 17-23 |
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
Biological interest in this peptide centers on its relationship to actin dynamics. Thymosin beta-4 binds monomeric actin through an LKKTET motif, and a short sequence carrying that motif can compete with other actin-binding proteins in cell-free preparations. Investigators propose that such competition shifts the balance between filament assembly and disassembly, which in turn affects how readily a cell extends protrusions and migrates. Most of the supporting observations come from cultured cells and purified protein systems rather than from intact organisms.
Animal work has examined the peptide in models of cardiac injury, skin wounding, and corneal repair, with reported outcomes covering cell migration, inflammatory cell influx, and tissue remodeling. Several of those experiments used the full-length protein or longer fragments instead of the seven-residue sequence, which makes direct comparison between reports difficult. Results are generally described as tissue-dependent, and effect sizes vary considerably across laboratories. Independent replication is uneven, so the overall picture is incomplete rather than settled.
Controlled human trials of the short fragment are scarce. Much of what appears in review articles is extrapolated from animal models or from studies of the parent protein, and literature searches return a larger body of cardiac and ophthalmic work on thymosin beta-4 than on the abbreviated peptide. Regulatory treatment differs by jurisdiction, and in several countries the material is handled as a research chemical rather than an approved therapeutic. Statements about human benefit should be read as provisional.
Lyophilized peptide powder is normally held desiccated at −20 °C, with −80 °C used for longer storage periods. Allowing a sealed vial to reach room temperature before opening is standard practice, because condensation forming on cold powder introduces moisture. Once dissolved, solutions are typically kept cold and shielded from light. Repeated freeze-thaw cycles are avoided because they encourage aggregation and gradual loss of material. These conventions are general to synthetic peptides rather than unique to any one sequence.
Purity and identity are separate measurements and are often confused. Reverse-phase high-performance liquid chromatography, usually with ultraviolet detection near 214 nanometres, reports the share of total peak area belonging to the target compound. Mass spectrometry by electrospray or matrix-assisted laser desorption then checks whether the observed mass matches the expected sequence. Neither measurement alone shows that a vial holds the intended peptide. Peptide content, meaning the fraction of vial mass that is genuine peptide rather than counter-ion, water or residual acid, is reported separately and is frequently lower than the stated purity figure.
Maureen Vevers. Chair of Governors, Askham Bryan College, York. For services to Further Education. Alexandra Ellen Vincent. Lately Chief Operating Officer, Arts and Humanities Research Council. For services to Research Funding. Suman Vohra. Vice Chair, Edinburgh Hindu Mandir and Cultural Centre. For services to the community in Edinburgh. Belinda Alison Voos. Lately Nurse Consultant in Paediatric Neurosurgery, Great Ormond Street Hospital for Children NHS Foundation Trust. For services to Paediatric Neurosurgical Nursing. Dorothy Helen Wagstaff. Founder, CASCAID. For services to Charity. David Walker. Chair of Trustees, Horizons Specialist Academy Trust. For services to Education. Susan Walker. Chief Commissioner, Girlguiding Scotland. For services to Young People. David Wallace. Senior Fleet Staff Engineer, Royal National Lifeboat Institution. For voluntary service to Maritime Safety. Lady (Julia Elizabeth) Walport (Dr. Julia Neild). Lately Trustee, The Amber Trust and Trustee, Ealing Youth Orchestra. For services to Young People and to Charity. Keith Norman Walton. Founder, Severnside Community Rail Partnership. For services to Urban Rail Transport in Bristol. John Ward. Chair, Charles and Elsie Sykes Trust. For services to Charity and to the community in Harrogate, North Yorkshire. Pamela Joan Ward. For services to the community in Whipsnade, Bedfordshire. William John Ward. For services to the community in the New Forest, Hampshire. Edward Charles Warner. Disability and Access Ambassador, Cabinet Office Disability Unit. For services to Disabled People.
==== Reduced probability of contamination ==== DMF-based workflows, particularly those using a closed configuration with a top-plate ground electrode, have been shown to be less susceptible to outside contamination compared to some conventional laboratory workflows. This can be attributed to minimal user interaction during automated steps, and the fact that the smaller volumes are less exposed to environmental contaminants than larger volumes which would need to be exposed to open air during mixing. Ruan et al. observed minimal contamination from exogenous nonhuman DNA and no cross-contamination between samples while using their DMF-based digital whole genome sequencing system.
Women who became pregnant within approximately six months of the final dose showed vaccine efficacy estimates between 57% and 86% against parasitaemia in pregnancy. Because malaria and HIV infections frequently overlap geographically, PfSPZ Vaccine has been studied in HIV-positive adults. A randomized, double-blind, placebo-controlled trial in Tanzania administered five intravenous doses to HIV-negative and well-controlled HIV-positive participants. The vaccine was safe in both groups, but protection against CHMI was observed only in HIV-negative individuals, with an estimated vaccine efficacy of 80% in HIV-negative adults and no measurable efficacy in the HIV-positive cohort. Serological profiling indicated that HIV infection did not markedly diminish the magnitude of antibody responses to key sporozoite antigens, although cellular correlates of protection appear impaired in HIV-positive individuals. Recent analyses have examined the immune targets associated with PfSPZ-induced protection. Whole-proteome antibody profiling in Tanzanian trial participants revealed that vaccination elicits a focused IgG and IgM response to a limited set of Plasmodium falciparum antigens, including circumsporozoite protein and several liver- and blood-stage proteins. A whole-genome sieve analysis of parasites obtained from vaccinated and placebo recipients in West African field trials identified distinct parasite polymorphisms associated with vaccine breakthrough infections.
The Times of India noted that these statements highlighted a disconnect between distributor-level performance and theatre-level earnings, suggesting that while certain distributors may have struggled due to high acquisition costs, individual cinemas in multiple territories were able to generate profits from theatrical screenings.
Sources: en.wikipedia.org
In yeast and many bacteria, alcohol dehydrogenase plays an important part in fermentation: Pyruvate resulting from glycolysis is converted to acetaldehyde and carbon dioxide, and the acetaldehyde is then reduced to ethanol by an alcohol dehydrogenase called ADH1. The purpose of this latter step is the regeneration of NAD+, so that the energy-generating glycolysis can continue. Humans exploit this process to produce alcoholic beverages, by letting yeast ferment various fruits or grains. Yeast can produce and consume their own alcohol. The main alcohol dehydrogenase in yeast is larger than the human one, consisting of four rather than just two subunits. It also contains zinc at its catalytic site. Together with the zinc-containing alcohol dehydrogenases of animals and humans, these enzymes from yeasts and many bacteria form the family of "long-chain"-alcohol dehydrogenases. Brewer's yeast also has another alcohol dehydrogenase, ADH2, which evolved out of a duplicate version of the chromosome containing the ADH1 gene. ADH2 is used by the yeast to convert ethanol back into acetaldehyde, and it is expressed only when sugar concentration is low. Having these two enzymes allows yeast to produce alcohol when sugar is plentiful (and this alcohol then kills off competing microbes), and then continue with the oxidation of the alcohol once the sugar, and competition, is gone.
=== Imaging === The SBP-Tag will also bind to streptavidin or streptavidin reagents in solution. Applications of these engineered associations include the visualization of specific proteins within living cells, monitoring of the kinetics of the translation of individual proteins in an in vitro translation system, control of the integration of a multi-spanning membrane protein into the endoplasmic reticulum by fusing the SBP-Tag to the N-terminal translocation sequence and then halting integration with streptavidin and restarting integration with biotin. Fluorescent streptavidin reagents (e.g. streptavidin-HRP) can be used to visualize the SBP-tag by immunoblotting of SDS-PAGE. Additionally, antibodies to the SBP-tag are available commercially.
4 Cytc2+ + O2 + 8H+inside → 4 Cytc3+ + 2 H2O + 4H+outside Although the heme proteins are the most important class of iron-containing proteins, the iron–sulfur proteins are also very important, being involved in electron transfer, which is possible since iron can exist stably in either the +2 or +3 oxidation states. These have one, two, four, or eight iron atoms that are each approximately tetrahedrally coordinated to four sulfur atoms; because of this tetrahedral coordination, they always have high-spin iron. The simplest of such compounds is rubredoxin, which has only one iron atom coordinated to four sulfur atoms from cysteine residues in the surrounding peptide chains. Another important class of iron–sulfur proteins is the ferredoxins, which have multiple iron atoms. Transferrin does not belong to either of these classes. The ability of sea mussels to maintain their grip on rocks in the ocean is facilitated by their use of organometallic iron-based bonds in their protein-rich cuticles. Based on synthetic replicas, the presence of iron in these structures increased elastic modulus 770 times, tensile strength 58 times, and toughness 92 times. The amount of stress required to permanently damage them increased 76 times.
Sources: en.wikipedia.org
Meghan Gallacher resigns as the party's deputy leader, citing a "potential risk to the reputation of our party and the leadership contest" after reports that Ross had previously suggested Russell Findlay should succeed him. The government faces questions about the appointment of Emily Middleton to a senior civil service role, as she has been previously linked to previous donations to the Labour Party. A group of MPs call on the government of Azerbaijan to free an academic from the London School of Economics and Political Science who was detained after writing articles critical of the country's environmental policies. British American academic Alan M. Taylor is appointed to the Bank of England's interest rate-setting committee. The UK government confirms that victims of the contaminated blood scandal will begin receiving compensation before the end of the year, with some being entitled to more than £2.5m. 17 August – It is reported that the Register of Members' Interests shows Reform UK leader Nigel Farage as Britain's highest earning MP, with a monthly salary of £96,000 on top of what he is paid as an MP. The majority of his earnings come from his presenting role on GB News. Farage subsequently says the amount is not a monthly sum, but represents presenting and consultancy work done since April. SNP MSP John Mason is stripped of the party whip after a Twitter post in which he said that Israel's actions in Gaza did not amount to "genocide", something a party spokesperson describes as "completely unacceptable".
== Occurrence and production == Polonium is a very rare element in nature because of the short half-lives of all its isotopes. Nine isotopes, from 210 to 218 inclusive, occur in traces as decay products: 210Po, 214Po, and 218Po occur in the decay chain of 238U; 211Po and 215Po occur in the decay chain of 235U; 212Po and 216Po occur in the decay chain of 232Th; and 213Po and 217Po occur in the decay chain of 237Np. (No primordial 237Np survives, but traces of it are continuously regenerated through (n,2n) knockout reactions in natural 238U. The ratio of neptunium to uranium is around 1 to 1012, but having a shorter half-life the ratio in terms of radioactivity is around 1 to 109. 217Po only occurs if 225Ra decays to 221Rn, with a probability of 0.000026, and then the 221Rn decays to 217Po with probability 0.22.) Of these, 210Po is the only isotope with a half-life longer than 3 minutes. Polonium can be found in uranium ores at about 0.1 mg per metric ton (1 part in 1010), which is approximately 0.2% of the abundance of radium. The amounts in the Earth's crust are not harmful. Polonium has been found in tobacco smoke from tobacco leaves grown with phosphate fertilizers. Because it is present in small concentrations, isolation of polonium from natural sources is a tedious process. The largest batch of the element ever extracted, performed in the first half of the 20th century, contained only 40 Ci (1.5 TBq) (9 mg) of polonium-210 and was obtained by processing 37 tonnes of residues from radium production.
=== Analogues === Close analogues of phenelzine include the amphetamine and hydrazine derivatives pheniprazine (α-methylphenelzine; the corresponding amphetamine analogue) and metfendrazine (α,N-dimethylphenelzine; the corresponding methamphetamine analogue), among others. Other analogues of phenelzine are its deuterated isotopologues α,α-dideuterophenelzine (d2-phenelzine) and α,α,β,β-tetradeuterophenelzine (d4-phenelzine), which show strongly potentiated pharmacological activity compared to phenelzine.
Sources: en.wikipedia.org
No. Thymosin beta-4 is a 43-residue protein, while TB-500 matches only residues 17 to 23 of that chain. The two are related but differ in size, and a method that identifies one does not automatically identify the other.
It corresponds to the actin-binding region of thymosin beta-4. Commercial synthesis reproduces that seven-residue stretch, usually with an acetyl group on the N-terminus.
It is not authorised as a medicine in the United States or the European Union and is distributed as a research chemical. Labels consequently carry research-use-only statements rather than clinical indications.
TB-500 is a name used for a short synthetic peptide fragment taken from the actin-binding region of thymosin beta-4. Material sold under this label is usually a lyophilized powder supplied for laboratory research rather than a licensed medicine. The commonly cited sequence is LKKTETQ.